NASDAQ$SIGA

SIGA Technologies, Inc · Q3 2020 earnings

Q3 2020 earnings · · Investor relations

Briefing

SIGA Technologies' financial performance significantly improved in Q3 2020, driven by increased TPOXX® deliveries.

SIGA Technologies reported a substantial increase in revenue and net income for the third quarter of 2020. The company's performance was driven by the delivery of approximately 134,000 courses of oral TPOXX® to the Strategic National Stockpile (SNS). SIGA has also seen growth in their international business, with the Public Health Agency of Canada announcing their intent to purchase up to 33,300 courses of oral TPOXX®.

  • SIGA delivered approximately 134,000 courses of oral TPOXX® to the SNS in Q3 2020, recognizing $41.4 million in revenue.
  • The Public Health Agency of Canada (PHAC) intends to purchase up to 33,300 courses of oral TPOXX® within five years.
  • SIGA repurchased approximately 0.9 million shares of its common stock for $5.6 million during Q3 2020.
  • Total deliveries of oral TPOXX® under the 19C BARDA Contract are expected to total approximately 363,000 courses for the calendar year 2020, resulting in annual revenues of approximately $113 million.

Headline financials

Total Revenue

$44.3M

Previous: $8.11M+445.7%
EPS (adj)

$0.31

Previous: -$0.01+3200.0%
Capital Expenditures

-$15.5K

Previous: -$29.1K+46.7%
Free Cash Flow

$24.2M

Previous: -$1.23M+2057.4%
Net Income

$24.2M

Previous: -$1.21M+2105.9%
Operating Income

$32.9M

Previous: $661K+4880.2%
Gross Profit

$38.7M

Previous: $7.37M+424.8%
Cash & Equivalents

$78.7M

Previous: $78.1M+0.7%
Total Assets

$141M

Previous: $203M-30.3%
Stock-Based Comp

$381K

Previous: $761K-50.0%

Revenue & EPS history

SIGA Technologies · Revenue · Quarterly

$44.3M

Q3 2020+445.7%vs Q3 2019
Beat estimate in 0 of 1 quarters(0%)
ActualEstimate

Revenue by segment

SIGA Technologies · $44.3M total across 2 segments · Q3 2020

  • Product Sales
    $41.8M+967.9%
  • R&D Revenues
    $2.45M-41.6%

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2020

Historical avgQ3 2020

-0.2%

Avg return

Earnings day

+0.5%

Avg return

5 days after

+2.4%

Avg return

30 days after

41%

26 / 64 earnings

Positive

+31.9%

Q4 2023

Best reaction

-27.8%

Q1 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.4%-5.5%-8.5%
Q4 2025-3.0%-3.4%-22.8%
Q3 2025-20.2%-24.0%-24.1%
Q1 2025+4.4%+9.0%+10.8%
Q4 2024+7.0%+0.5%+6.4%
Q3 2024-1.9%-8.5%-9.8%
Q2 2024-12.8%-14.3%-9.5%
Q1 2024-27.8%-28.2%-26.7%
Q4 2023+31.9%+49.9%+88.3%
Q3 2023-4.4%-2.2%+16.9%
Q2 2023-3.7%-10.0%-21.9%
Q1 2023+5.1%+1.8%-0.7%
Q4 2022-3.8%-7.8%-13.4%
Q3 2022+7.5%+9.8%+1.1%
Q2 2022+27.4%+24.6%-21.0%
Q1 2022+3.6%+4.0%+60.7%
Q4 2021+3.0%+6.6%+22.4%
Q3 2021-0.7%+0.0%+2.8%
Q2 2021-2.9%-4.0%+9.1%
Q1 2021-0.7%-8.4%-10.4%
Q4 2020+1.7%+9.3%+1.2%
Q3 2020+2.0%+3.4%-0.9%
Q2 2020+14.3%+5.5%-1.9%
Q1 2020-1.4%+1.4%+2.9%
Q4 2019+10.4%+0.4%+0.2%
Q3 2019-3.2%-1.8%-19.8%
Q2 2019+0.2%-1.7%+2.7%
Q1 2019+1.5%-1.3%-12.8%
Q4 2018-4.4%-1.6%-6.3%
Q3 2018+8.4%+5.7%+29.1%
Q2 2018+0.3%+7.7%+1.4%
Q1 2018-0.5%+2.4%-3.9%
Q4 2017-0.6%-7.0%-2.3%
Q3 2017+2.8%-1.1%+3.9%
Q2 2017-1.6%-1.6%-1.9%
Q1 2017-0.3%+0.6%-8.0%
Q4 2016-0.6%+0.0%-4.1%
Q3 2016-5.7%+3.8%+54.8%
Q2 2016+4.5%+4.1%+11.4%
Q1 2016+1.1%
Q4 2015+1.1%
Q3 2015+2.4%
Q2 2015-0.9%
Q1 2015+5.7%
Q4 2014-1.3%
Q3 2014-0.7%
Q2 2014-4.9%
Q1 2014-1.4%
Q4 2013-2.7%
Q3 2013-3.5%
Q2 2013-2.8%
Q1 2011-2.4%
Q4 2012-2.5%
Q3 2012+6.5%
Q2 2012+5.3%
Q1 2012+4.5%
Q4 2011-1.4%
Q4 2009-1.4%
Q3 2010-6.1%
Q3 2011-6.1%
Q2 2011-12.0%
Q2 2010-12.0%
Q4 2010-12.0%
Q1 2010-1.4%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro